CIK: 1690298 - Address: C/o Phathom Pharmaceuticals, Inc., 100 Campus Drive, Suite 102, Florham Park, NJ 07932
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/26/24 16:05
3/22/24
PHATPhathom Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsCurran TerrieNJDOP,Chief S-1549.110-17-4415D
4/7/23 15:19
4/6/23
PHATPhathom Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsCurran TerrieNJDOP,Chief P1017.820137191D
3/3/23 18:59
3/1/23
PHATPhathom Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsCurran TerrieNJDOP,Chief S-128.540-1-1178D
1/20/23 19:39
1/20/23
PHATPhathom Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsCurran TerrieNJDOP,Chief S.d-488.200-6-3179D
11/23/22 16:07
11/21/22
PHATPhathom Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsCurran TerrieNJDOP,Chief S-159.600-2-286D
5/16/22 20:45
5/13/22
PHATPhathom Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsCurran TerrieNJDOP,Chief P1527.410214665D
9/13/21 16:11
9/9/21
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsCurran TerrieCADM.d377.65050D
9/13/21 16:11
9/9/21
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsCurran TerrieCADS.d-12425.580-5-1000D
9/3/21 16:25
9/1/21
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsCurran TerrieCADM.dm3717.650490D
9/3/21 16:25
9/1/21
MYOVMyovant Sciences Ltd.CAHealthDrugPharmaceutical PreparationsCurran TerrieCADS.dm-1,21425.020-49-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact